- Investing Ideas
- Indian Pharmaceuticals & Biotech High ROE Growth Engines
Indian Pharmaceuticals & Biotech High ROE Growth Engines
Results
9
9 companies
Abbott India
Market Cap: ₹575.4b
Operates as a pharmaceutical company in India.
500488
₹27,076.90
7D
-2.5%
1Y
-18.5%
Ajanta Pharma
Market Cap: ₹458.7b
A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.
AJANTPHARM
₹3,672.80
7D
5.3%
1Y
36.7%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹455.5b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,689.10
7D
3.7%
1Y
-2.9%
Neuland Laboratories
Market Cap: ₹299.1b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹23,311.50
7D
2.0%
1Y
75.8%
CORONA Remedies
Market Cap: ₹130.7b
A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
CORONA
₹2,137.10
7D
3.8%
1Y
n/a
Shukra Pharmaceuticals
Market Cap: ₹18.2b
Manufactures and markets pharmaceutical products in India and internationally.
524632
₹41.43
7D
6.1%
1Y
130.8%
Sat Kartar Life
Market Cap: ₹1.9b
An ayurvedic healthcare company, provides ayurvedic products in India.
SATKARTAR
₹121.00
7D
1.6%
1Y
-29.5%
Aanjaay Industries
Market Cap: ₹592.2m
Does not have significant operations.
524322
₹24.98
7D
2.7%
1Y
22.9%
Colinz Laboratories
Market Cap: ₹201.2m
Manufactures, markets, and trades in pharmaceutical formulations in India.
531210
₹79.87
7D
-4.2%
1Y
84.5%